Deutsche Bank reissued their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a report issued on Wednesday morning, Borsen Zeitung reports. Deutsche Bank currently has a GBX 8,400 ($103.37) price target on the stock.
RB has been the subject of a number of other reports. CSFB reiterated a neutral rating on shares of Reckitt Benckiser Group in a research report on Thursday, April 30th. Kepler Capital Markets lifted their price target on shares of Reckitt Benckiser Group from GBX 6,700 ($82.45) to GBX 7,250 ($89.22) and gave the company a buy rating in a research report on Monday, May 4th. Barclays lifted their price objective on Reckitt Benckiser Group from GBX 7,900 ($97.22) to GBX 9,000 ($110.76) and gave the stock an overweight rating in a research report on Tuesday, June 23rd. Credit Suisse Group lifted their price objective on Reckitt Benckiser Group from GBX 7,000 ($86.14) to GBX 7,200 ($88.60) and gave the stock a neutral rating in a research report on Tuesday, July 28th. Finally, UBS Group restated a buy rating and set a GBX 8,400 ($103.37) price objective on shares of Reckitt Benckiser Group in a research report on Monday, July 27th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and thirteen have given a buy rating to the stock. The stock presently has an average rating of Buy and an average target price of GBX 7,655.56 ($94.21).
RB stock opened at GBX 7,706 ($94.83) on Wednesday. The firm has a 50 day moving average of GBX 7,441.20 and a 200-day moving average of GBX 6,629.16. Reckitt Benckiser Group has a 12-month low of GBX 73.44 ($0.90) and a 12-month high of GBX 8,191.30 ($100.80). The company has a current ratio of 0.56, a quick ratio of 0.40 and a debt-to-equity ratio of 130.80. The company has a market cap of $54.80 billion and a price-to-earnings ratio of -14.83.
The company also recently announced a dividend, which will be paid on Tuesday, September 29th. Shareholders of record on Thursday, August 20th will be paid a GBX 73 ($0.90) dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a yield of 0.94%. Reckitt Benckiser Group’s payout ratio is currently -39.06%.
In other news, insider Nicandro Durante bought 165 shares of the stock in a transaction on Wednesday, May 27th. The stock was purchased at an average cost of GBX 6,884 ($84.72) per share, with a total value of £11,358.60 ($13,978.10).
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: What causes a recession?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.